Delivery Order SPE2DE24D0021-SPE2D626F00YB
- Not listed
- Fisher Scientific Company L.L.C. has been awarded a delivery order valued at $1,167.00 by the Department of Defense's Medical Supply Chain for RGT RT PCR ROX AGPATH-ID ARRAYSCRIPT AMP diagnostic products. Awarded on November 5, 2025, with an ultimate completion date of November 21, 2025, this fixed-price contract with economic price adjustment represents a child order under a larger procurement vehicle. The award carries no set-aside designation, indicating Fisher Scientific competed in an...
- Fisher Scientific Company L.L.C. received a delivery order award valued at $2,748.00 for the provision of RT PCR RNA test kits with built-in hot start gel from the Department of Defense's Medical Supply Chain. The contract, awarded on November 6, 2025, is a fixed-price agreement with economic price adjustment provisions and carries an ultimate completion date of November 21, 2025. This delivery order represents a child contract with no set-aside designation, indicating open competition in the...
- Fisher Scientific Company L.L.C. was awarded a delivery order valued at $18,320.00 on November 28, 2025, for the provision of a Kit RT PCR RNA 1 step built-in hot start gel product. This fixed-price contract with economic price adjustment is scheduled for ultimate completion by December 8, 2025, and will be performed in Pittsburgh, Pennsylvania. The award was issued by the Department of Defense's Medical Supply Chain without a set-aside designation, indicating open competition among qualified...
- Fisher Scientific Company L.L.C. received a fixed-price delivery order valued at $4,280.28 from the Department of Defense's Medical Supply Chain for one kit of reverse transcription polymerase chain reaction (RT-PCR) DNA polymerase with a SuperScript3 platinum formulation. The award, issued on December 15, 2025, is expected to be completed by January 6, 2026, with performance occurring in Pittsburgh, Pennsylvania. This delivery order was issued without set-aside designation, indicating Fisher...
- Fisher Scientific Company L.L.C. has been awarded a delivery order contract by the Department of Defense Medical Supply Chain for a Kit RT PCR RNA DNA Polymer with a ceiling value of $1,604.00. The award was issued on October 30, 2025, with an ultimate completion date of November 14, 2025. This fixed-price contract with economic price adjustment represents a child contract under a larger procurement vehicle and involves no set-aside designation, indicating competition in an open federal...
- Fisher Scientific Company L.L.C. was awarded a delivery order valued at $1,560.26 by the Department of Defense's Medical Supply Chain for RT-PCR reverse transcriptase reagents with reduced ribonuclease activity, with a final completion date of December 19, 2025. This fixed-price delivery order with economic price adjustment carries no set-aside designation, indicating competition in an open federal procurement environment. The contract represents a child order under a larger vehicle,...
- Fisher Scientific Company L.L.C. was awarded a $4,010.00 fixed-price delivery order with economic price adjustment authority by the Department of Defense's Medical Supply Chain on December 30, 2025, for RT-PCR RNA/DNA polymer kit components with ultimate completion by January 14, 2026. The award, executed through a child contract arrangement at the Pittsburgh, Pennsylvania location, represents a routine procurement of specialized molecular diagnostic supplies supporting federal healthcare and...
- Fisher Scientific Company L.L.C. received a $4,178.20 fixed-price delivery order from the Department of Defense's Medical Supply Chain on January 10, 2026, for Kit RT PCR DNA Polymer 1 Step Superscipt3 Platin, with final delivery required by January 29, 2026. The award was issued without set-aside designation, indicating open competition. This delivery order represents a child contract under a larger indefinite delivery vehicle, enabling the Department of Defense to procure specialized molecular...
- Fisher Scientific Company L.L.C. was awarded a fixed-price delivery order valued at $2,485 by the Department of Defense's Medical Supply Chain on December 15, 2025, for SSIII 1-Step QRT-PCR 100 diagnostic test supplies. The contract, which is a child order under a larger vehicle, has an ultimate completion date of January 7, 2026, and will be performed in Pittsburgh, Pennsylvania. This delivery order represents routine procurement of quantitative reverse transcription polymerase chain reaction...
- Fisher Scientific Company L.L.C. was awarded a fixed-price delivery order with economic price adjustment valued at $2,485 by the Department of Defense's Medical Supply Chain on October 31, 2025. The delivery order, designated as SSIII 1-STEP QRT-PCR 100, represents a child award under a larger contracting vehicle and calls for the delivery of quantitative reverse transcription polymerase chain reaction (qRT-PCR) testing supplies to support molecular diagnostic operations. The order must be...
- SPE2DE24D0021Indefinite Delivery Contract
- SPE2DE24D0021-SPE2D626F00YBDelivery Order
Fisher Scientific Company L.L.C. received a delivery order award valued at $2,352.96 from the Department of Defense's Medical Supply Chain for kit reverse transcription polymerase chain reaction (RT-PCR) RNA with 1 step built-in hot start gel. This fixed-price delivery order, awarded on January 10, 2026, with an ultimate completion date of January 14, 2026, will be performed in Pittsburgh, Pennsylvania. The award carries no set-aside designation, indicating competitive procurement. This delivery order is a child contract under a larger procurement vehicle, leveraging Fisher Scientific's established position as a primary federal vendor for laboratory and diagnostic supplies to the DoD's Medical Supply Chain. Fisher Scientific, a major for-profit laboratory supply distributor registered with the System for Award Management since 2001, brings substantial federal procurement experience to this engagement. The company maintains a significant portfolio of contract awards from multiple federal agencies, including the Department of Veterans Affairs, National Institutes of Health components, and the Indian Health Service, supplying specialized diagnostic equipment, reagents, and medical supplies. The company's existing Blanket Purchase Agreement with the VA, valued at $1.65 million through September 2030, demonstrates its capacity to reliably deliver laboratory reagents and supplies supporting federal healthcare operations on a sustained basis. This RT-PCR delivery order aligns with Fisher Scientific's core competencies in providing diagnostic test kits supporting molecular biology applications across the federal government.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.4k | 1/9/26 |